Staging of multivessel percutaneous coronary interventions: An expert consensus statement from the Society for Cardiovascular Angiography and Interventions

James C. Blankenship, Issam D. Moussa, Charles C. Chambers, Emmanouil S. Brilakis, Thomas A. Haldis, Douglas A. Morrison, Gregory J. Dehmer

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Percutaneous coronary interventions (PCIs) to treat multivessel coronary artery disease (MVCAD) may involve single-vessel or multivessel interventions, performed in one or more stages. This consensus statement reviews factors that may influence choice of strategy and includes six recommendations to guide decisions regarding staging of PCI [1]. Every patient who undergoes PCI should receive optimal therapy for coronary disease, ideally before starting the procedure [2]. Multivessel PCI at the time of diagnostic catheterization should be considered only if informed consent included the risks and benefits of multivessel PCI and the risks and benefits of alternative treatments [3]. When considering multivessel PCI, the interventionist should develop a strategy regarding which stenoses to treat or evaluate, and their order, method, and timing. This strategy should maximize patient benefits, minimize patient risk, and consider the factors described in this article [4]. For planned multivessel PCI, additional vessel(s) should be treated only if the first vessel is treated successfully and if anticipated contrast and radiation doses and patient and operator conditions are favorable [5]. After the first stage of the planned multistage PCI, the need for subsequent PCI should be reviewed before it is performed [6]. Third party payers and quality auditors should recognize that multistage PCI for MVCAD is neither an indication of poor quality nor an attempt to increase reimbursement when performed according to recommendations in this article.

Original languageEnglish (US)
Pages (from-to)1138-1152
Number of pages15
JournalCatheterization and Cardiovascular Interventions
Volume79
Issue number7
DOIs
StatePublished - Jun 1 2012

Fingerprint

Percutaneous Coronary Intervention
Coronary Artery Disease
Health Insurance Reimbursement
Informed Consent
Catheterization
Coronary Disease
Pathologic Constriction
Radiation

Keywords

  • Percutaneous coronary intervention
  • Staging
  • Stenting

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Staging of multivessel percutaneous coronary interventions : An expert consensus statement from the Society for Cardiovascular Angiography and Interventions. / Blankenship, James C.; Moussa, Issam D.; Chambers, Charles C.; Brilakis, Emmanouil S.; Haldis, Thomas A.; Morrison, Douglas A.; Dehmer, Gregory J.

In: Catheterization and Cardiovascular Interventions, Vol. 79, No. 7, 01.06.2012, p. 1138-1152.

Research output: Contribution to journalArticle

Blankenship, James C. ; Moussa, Issam D. ; Chambers, Charles C. ; Brilakis, Emmanouil S. ; Haldis, Thomas A. ; Morrison, Douglas A. ; Dehmer, Gregory J. / Staging of multivessel percutaneous coronary interventions : An expert consensus statement from the Society for Cardiovascular Angiography and Interventions. In: Catheterization and Cardiovascular Interventions. 2012 ; Vol. 79, No. 7. pp. 1138-1152.
@article{86664b313f4b4821894907b24a4f0374,
title = "Staging of multivessel percutaneous coronary interventions: An expert consensus statement from the Society for Cardiovascular Angiography and Interventions",
abstract = "Percutaneous coronary interventions (PCIs) to treat multivessel coronary artery disease (MVCAD) may involve single-vessel or multivessel interventions, performed in one or more stages. This consensus statement reviews factors that may influence choice of strategy and includes six recommendations to guide decisions regarding staging of PCI [1]. Every patient who undergoes PCI should receive optimal therapy for coronary disease, ideally before starting the procedure [2]. Multivessel PCI at the time of diagnostic catheterization should be considered only if informed consent included the risks and benefits of multivessel PCI and the risks and benefits of alternative treatments [3]. When considering multivessel PCI, the interventionist should develop a strategy regarding which stenoses to treat or evaluate, and their order, method, and timing. This strategy should maximize patient benefits, minimize patient risk, and consider the factors described in this article [4]. For planned multivessel PCI, additional vessel(s) should be treated only if the first vessel is treated successfully and if anticipated contrast and radiation doses and patient and operator conditions are favorable [5]. After the first stage of the planned multistage PCI, the need for subsequent PCI should be reviewed before it is performed [6]. Third party payers and quality auditors should recognize that multistage PCI for MVCAD is neither an indication of poor quality nor an attempt to increase reimbursement when performed according to recommendations in this article.",
keywords = "Percutaneous coronary intervention, Staging, Stenting",
author = "Blankenship, {James C.} and Moussa, {Issam D.} and Chambers, {Charles C.} and Brilakis, {Emmanouil S.} and Haldis, {Thomas A.} and Morrison, {Douglas A.} and Dehmer, {Gregory J.}",
year = "2012",
month = "6",
day = "1",
doi = "10.1002/ccd.23353",
language = "English (US)",
volume = "79",
pages = "1138--1152",
journal = "Catheterization and Cardiovascular Interventions",
issn = "1522-1946",
publisher = "Wiley-Liss Inc.",
number = "7",

}

TY - JOUR

T1 - Staging of multivessel percutaneous coronary interventions

T2 - An expert consensus statement from the Society for Cardiovascular Angiography and Interventions

AU - Blankenship, James C.

AU - Moussa, Issam D.

AU - Chambers, Charles C.

AU - Brilakis, Emmanouil S.

AU - Haldis, Thomas A.

AU - Morrison, Douglas A.

AU - Dehmer, Gregory J.

PY - 2012/6/1

Y1 - 2012/6/1

N2 - Percutaneous coronary interventions (PCIs) to treat multivessel coronary artery disease (MVCAD) may involve single-vessel or multivessel interventions, performed in one or more stages. This consensus statement reviews factors that may influence choice of strategy and includes six recommendations to guide decisions regarding staging of PCI [1]. Every patient who undergoes PCI should receive optimal therapy for coronary disease, ideally before starting the procedure [2]. Multivessel PCI at the time of diagnostic catheterization should be considered only if informed consent included the risks and benefits of multivessel PCI and the risks and benefits of alternative treatments [3]. When considering multivessel PCI, the interventionist should develop a strategy regarding which stenoses to treat or evaluate, and their order, method, and timing. This strategy should maximize patient benefits, minimize patient risk, and consider the factors described in this article [4]. For planned multivessel PCI, additional vessel(s) should be treated only if the first vessel is treated successfully and if anticipated contrast and radiation doses and patient and operator conditions are favorable [5]. After the first stage of the planned multistage PCI, the need for subsequent PCI should be reviewed before it is performed [6]. Third party payers and quality auditors should recognize that multistage PCI for MVCAD is neither an indication of poor quality nor an attempt to increase reimbursement when performed according to recommendations in this article.

AB - Percutaneous coronary interventions (PCIs) to treat multivessel coronary artery disease (MVCAD) may involve single-vessel or multivessel interventions, performed in one or more stages. This consensus statement reviews factors that may influence choice of strategy and includes six recommendations to guide decisions regarding staging of PCI [1]. Every patient who undergoes PCI should receive optimal therapy for coronary disease, ideally before starting the procedure [2]. Multivessel PCI at the time of diagnostic catheterization should be considered only if informed consent included the risks and benefits of multivessel PCI and the risks and benefits of alternative treatments [3]. When considering multivessel PCI, the interventionist should develop a strategy regarding which stenoses to treat or evaluate, and their order, method, and timing. This strategy should maximize patient benefits, minimize patient risk, and consider the factors described in this article [4]. For planned multivessel PCI, additional vessel(s) should be treated only if the first vessel is treated successfully and if anticipated contrast and radiation doses and patient and operator conditions are favorable [5]. After the first stage of the planned multistage PCI, the need for subsequent PCI should be reviewed before it is performed [6]. Third party payers and quality auditors should recognize that multistage PCI for MVCAD is neither an indication of poor quality nor an attempt to increase reimbursement when performed according to recommendations in this article.

KW - Percutaneous coronary intervention

KW - Staging

KW - Stenting

UR - http://www.scopus.com/inward/record.url?scp=84861994598&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861994598&partnerID=8YFLogxK

U2 - 10.1002/ccd.23353

DO - 10.1002/ccd.23353

M3 - Article

C2 - 22072562

AN - SCOPUS:84861994598

VL - 79

SP - 1138

EP - 1152

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

SN - 1522-1946

IS - 7

ER -